KRYOPROTEINE UND IHRE BEDEUTUNG FUER DIE DERMATOLOGIE = CRYOPROTEINES ET LEUR INTERET EN DERMATOLOGIEGOERZ G; LISSNER R.1979; Z. HAUTKRANKH.; DEU; DA. 1979; VOL. 54; NO 3; PP. 90-98; BIBL. 54 REF.Article

HAEUFIGKEIT VON HBS-ANTIGEN UND ANTI-HBS BEI PORPHYRIA CUTANEA TARDA = FREQUENCE DE L'ANTIGENE HBS ET ANTI HBS CHEZ DES PATIENTS AVEC PORPHYRIE CUTANEE TARDIVEGOERZ G; UTHEMAN H; LISSNER R et al.1979; T. GASTROENTEROL.; DEU; DA. 1979; VOL. 17; NO 5; PP. 296-300; ABS. ENG; BIBL. 28 REF.Article

EINFLUSS VON P-AMINOBENZOESAEURE AUF DIE HEXACHLORBENZOL-INDUZIERTE PORPHYRIE DER RATTE = INFLUENCE DE L'ACIDE P-AMINOBENZOIQUE SUR LA PORPHYRIE DU RAT INDUITE PAR L'HEXACHLOROBENZENEGOERZ G; SICK N; VIZETHUM W et al.1980; ARZNEIMITTEL-FORSCH.; DEU; DA. 1980; VOL. 30; NO 5; PP. 817-821; ABS. ENG; BIBL. 28 REF.Article

DRUG MONOOXYGENASE ACTIVITY IN THE HARDERIAN GLAND.KRIEG T; GOERZ G; LISSNER R et al.1978; BIOCHEM. PHARMACOL.; G.B.; DA. 1978; VOL. 27; NO 4; PP. 575-577; BIBL. 21 REF.Article

HUMAN-PHARMACOLOGICAL INVESTIGATIONS ON THE PLATELET ADHESIVENESS- AND AGGREGATION-INHIBITING EFFECT OF EMD 26644, AN OXAZOLYL-THIO-PROPIONIC ACID DERIVATE.JACOBI E; LEOPOLD G; LISSNER R et al.1978; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1978; VOL. 16; NO 3; PP. 136-141; BIBL. 12 REF.Article

A CLINICAL STUDY OF THE TOLERANCE AND SOFETY OF A BETA -PROPIOLACTONE-TREATED IMMUNOGLOBULINMONDORF AW; STEPHAN W; UTHEMANN H et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 11; PP. 1928-1930; ABS. GER; BIBL. 7 REF.Article

ON THE MUTAGENICITY AND IMMUNOGENICITY OF A BETA -PROPIOLACTONE-TREATED THERAPEUTIC IGG-PREPARATIONPINCUS JH; MORTELMANS K; TANAKA W et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 11; PP. 1924-1928; ABS. GER; BIBL. 21 REF.Article

DIE PORPHYRIN-STOFFWECHSELSTOERUNGEN DES MENSCHEN-ERYTHROPOETISCHE UND HEPATISCHE PORPHYRIEN = LES TROUBLES DU METABOLISME DES PORPHYRINES CHEZ L'HOMME. PORPHYRIES ERYTHROPOIETIQUES ET HEPATIQUESGOERZ G; KRIEG T; LISSNER R et al.1979; Z. HAUTKRANKH.; DEU; DA. 1979; VOL. 54; NO 4; PP. 153-168; BIBL. 54 REF.Article

HEXACHLORBENZOL (HCB)-BEDINGTE PORPHYRIE DER RATTE. EINFLUSS VON HCB-METABOLITEN AUF DIE HAEMBIOSYNTHESE = PORPHYRIE EXPERIMENTALE PAR HEXACHLOROBENZENE CHEZ LES RATS. INFLUENCE DES METABOLISMES DE L'HCB SUR LA BIOSYNTHESE DE L'HEMEGOERZ G; VIZETHUM W; BOLSEN K et al.1978; ARCH. DERMATOL. RES.; DEU; DA. 1978; VOL. 263; NO 2; PP. 189-196; ABS. ENG; BIBL. 27 REF.Article

EINFLUSS VON THEOPHYLLIN AUF DIE HEXACHLORBENZOLINDUZIERTE PORPHYRIE = INFLUENCE DE LA THEOPHYLLINE SUR LA PORPHYRIE INDUITE PAR L'HEXACHLOROBENZENEGOERZ G; BOLSEN K; STAIB AH et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 9; PP. 1446-1447; ABS. ENG; BIBL. 15 REF.Article

THE CHEMOTHERAPY OF RODENT MALARIA. XXX. THE ENIGMAS OF THE "NS LINES" OF P. BERGHEI.PETERS W; CHANCE ML; LISSNER R et al.1978; ANN. TROP. MED. PARASITOL.; G.B.; DA. 1978; VOL. 72; NO 1; PP. 23-36; BIBL. 1 P. 1/2Article

PHARMACOKINETICS AND METABOLISM OF THEOPHYLLINE IN PATIENTS WITH LIVER DISEASESSTAIB AH; SCHUPPAN D; LISSNER R et al.1980; INT. J. CLIN. PHARMACOL. THER. TOXICOL.; DEU; DA. 1980; VOL. 18; NO 11; PP. 500-502; BIBL. 8 REF.Article

Circadian rhythm of soluble interleukin-2 receptor in healthy individualsLEMMER, B; SCHWULERA, U; THRUN, A et al.European cytokine network (Montrouge). 1992, Vol 3, Num 3, pp 335-336, issn 1148-5493Article

Wechselwirkungen zwischen Theophyllin und den arzneimittelmetabolisierenden Leberenzymen der Ratte = Interactions entre la théophylline et la «drug-metabolizing enzyme» chez le rat = Interactions between theophylline and drug metabolizing enzymes in the ratLISSNER, R; MERK, H; BOLSEN, K et al.Arzneimittel-Forschung. 1985, Vol 35, Num 12, pp 1825-1827, issn 0004-4172Article

A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga-like toxins and EHEC-hemolysin of Escherichia coli O157:H7LISSNER, R; SCHMIDT, H; KARCH, H et al.Infection. 1996, Vol 24, Num 5, pp 378-383, issn 0300-8126Conference Paper

Antibody reactivity and fecal recovery of bovine immunoglobulins following oral administration of a colostrum concentrate from cows (Lactobin) to healthy volunteersLISSNER, R; THÜRMANN, P. A; MERZ, G et al.International journal of clinical pharmacology and therapeutics. 1998, Vol 36, Num 5, pp 239-245, issn 0946-1965Article

Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparationsAUTENRIETH, I. B; SCHWARZKOPF, A; EWALD, J. H et al.Antimicrobial agents and chemotherapy. 1995, Vol 39, Num 9, pp 1965-1969, issn 0066-4804Article

Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myelomaTHÜRMANN, P. A; SONNENBURG, C; VALENTOVA, K et al.European journal of clinical pharmacology. 2001, Vol 57, Num 3, pp 235-241, issn 0031-6970Article

IgA/IgM and secretory immunityRÜSSMANN, H; LISSNER, R; SCHMIDT, H et al.Sepsis (Boston). 1999, Vol 3, Num 3, pp 219-224, issn 1385-0229Article

The effect of antenatal intravenous immunoglobulin on ascending intrauterine infection after preterm premature rupture of the membranes: a pilot studyHÖCKEL, M; QUEISSER-LUFT, A; BECK, T et al.Journal of perinatal medicine. 1992, Vol 20, Num 2, pp 101-110, issn 0300-5577Article

Importance of simultaneous active cytomegalovirus and Epstein-Barr virus infection in renal transplantationMEYER, T; SCHOLZ, D; WARNECKE, G et al.Clinical and diagnostic virology. 1996, Vol 6, Num 2-3, pp 79-91, issn 0928-0197Article

Tolerance and cerebrospinal fluid pharmacokinetics of intrathecally administered human natural interleulin-2: a phase I trialRÖSENER, M; SCHWULERA, U; MENKE, G et al.European cytokine network (Montrouge). 1993, Vol 4, Num 3, pp 189-195, issn 1148-5493Article

Interleukin-2 and blood brain barrier in cats: pharmacokinetics and tolerance following intrathecal and intravenous administrationMARTIN, R; SCHWULERA, U; MENKE, G et al.European cytokine network (Montrouge). 1992, Vol 3, Num 4, pp 399-406, issn 1148-5493Article

Shiga toxin-producing Escherichia coli infections in GermanyKARCH, H; HUPPERTZ, H.-I; BOCKEMÜHL, J et al.Journal of food protection. 1997, Vol 60, Num 11, pp 1454-1457, issn 0362-028XConference Paper

Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrumBITZAN, M. M; GOLD, B. D; PHILPOTT, D. J et al.The Journal of infectious diseases. 1998, Vol 177, Num 4, pp 955-961, issn 0022-1899Article